| LINE ITEM (USD / %) | FY 2025
FILED 2025-08-30 | FY 2024
FILED 2024-08-31 | FY 2023
FILED 2023-08-26 |
|---|---|---|---|
| Revenue (Total Sales) | $2.80B | $2.97B | $3.49B |
| YoY Revenue Growth % | -5.9% | -14.8% | — |
| Gross Profit | $365.1M | $433.5M | — |
| Gross Margin % | 13.0% | 14.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $57.2M | $100.2M | $300.7M |
| Operating Margin % | 2.0% | 3.4% | 8.6% |
| Net Income (GAAP) | $25.7M | $13.0M | $215.9M |
| EBITDA (Normalized) | $88.7M | $136.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $128.9M | $143.9M | $294.5M |
| Capital Expenditures (CapEx) | $39.4M | $45.0M | — |
| Free Cash Flow (FCF) | $89.5M | $98.9M | $294.5M |
| FCF Margin % | 3.2% | 3.3% | 8.4% |
| Return on Invested Capital (ROIC %) | 2.8% | 4.9% | — |
| Cash & Short-Term Equivalents | $181.7M | $262.5M | — |
| Total Debt (Short + Long Term) | $541.0M | $637.7M | — |
| Total Stockholders' Equity | $1.23B | $1.24B | — |